CN113416712B - 一株宽裂解谱沙门氏菌噬菌体及其应用 - Google Patents
一株宽裂解谱沙门氏菌噬菌体及其应用 Download PDFInfo
- Publication number
- CN113416712B CN113416712B CN202110742848.1A CN202110742848A CN113416712B CN 113416712 B CN113416712 B CN 113416712B CN 202110742848 A CN202110742848 A CN 202110742848A CN 113416712 B CN113416712 B CN 113416712B
- Authority
- CN
- China
- Prior art keywords
- salmonella
- phage
- bacteriophage
- wxlsgp006
- wide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000607142 Salmonella Species 0.000 title claims abstract description 145
- 230000009089 cytolysis Effects 0.000 title claims abstract description 40
- 241001515965 unidentified phage Species 0.000 title claims abstract description 34
- 238000001228 spectrum Methods 0.000 title claims abstract description 22
- -1 pplication Species 0.000 title description 3
- 239000003814 drug Substances 0.000 claims abstract description 20
- 239000001963 growth medium Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 8
- 241000607683 Salmonella enterica subsp. enterica serovar Pullorum Species 0.000 claims description 7
- 239000008365 aqueous carrier Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- 230000002101 lytic effect Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000645 desinfectant Substances 0.000 claims description 4
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 239000010865 sewage Substances 0.000 claims description 3
- 241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 claims description 2
- 241000607132 Salmonella enterica subsp. enterica serovar Gallinarum Species 0.000 claims description 2
- 241000607128 Salmonella enterica subsp. enterica serovar Infantis Species 0.000 claims description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 claims description 2
- 230000002934 lysing effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 238000012258 culturing Methods 0.000 abstract description 11
- 238000005336 cracking Methods 0.000 abstract description 9
- 239000007787 solid Substances 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 125000001475 halogen functional group Chemical group 0.000 abstract description 3
- 238000001066 phage therapy Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 description 13
- 238000004659 sterilization and disinfection Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 206010059866 Drug resistance Diseases 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 238000009630 liquid culture Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 208000019331 Foodborne disease Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000001143 conditioned effect Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000012137 tryptone Substances 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 2
- 206010039438 Salmonella Infections Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010039447 salmonellosis Diseases 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001977 bismuth sulfite agar Substances 0.000 description 1
- QSBNOZODKXUXSP-UHFFFAOYSA-K bismuth;azane;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound N.[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QSBNOZODKXUXSP-UHFFFAOYSA-K 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229960001506 brilliant green Drugs 0.000 description 1
- HXCILVUBKWANLN-UHFFFAOYSA-N brilliant green cation Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 HXCILVUBKWANLN-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- ZUJIHUXXWRPGPY-UHFFFAOYSA-H dibismuth;trisulfite Chemical compound [Bi+3].[Bi+3].[O-]S([O-])=O.[O-]S([O-])=O.[O-]S([O-])=O ZUJIHUXXWRPGPY-UHFFFAOYSA-H 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000001320 lysogenic effect Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 1
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110742848.1A CN113416712B (zh) | 2021-06-30 | 2021-06-30 | 一株宽裂解谱沙门氏菌噬菌体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110742848.1A CN113416712B (zh) | 2021-06-30 | 2021-06-30 | 一株宽裂解谱沙门氏菌噬菌体及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113416712A CN113416712A (zh) | 2021-09-21 |
CN113416712B true CN113416712B (zh) | 2022-04-26 |
Family
ID=77717963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110742848.1A Active CN113416712B (zh) | 2021-06-30 | 2021-06-30 | 一株宽裂解谱沙门氏菌噬菌体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113416712B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114107222B (zh) * | 2021-11-23 | 2023-07-11 | 华中农业大学 | 一株广谱耐高温沙门菌烈性噬菌体及其应用 |
CN114717199B (zh) * | 2022-02-25 | 2023-06-20 | 山东农业大学 | 一株不具转导耐药基因能力的沙门菌噬菌体ckt1及其应用 |
CN114874996B (zh) * | 2022-03-24 | 2023-08-08 | 华中农业大学 | 一种沙门氏菌噬菌体组合物及其应用 |
CN114921423B (zh) * | 2022-06-28 | 2023-11-28 | 华南农业大学 | 一株多重耐药肯塔基沙门菌烈性噬菌体及其制备方法和应用 |
CN115747172A (zh) * | 2022-10-24 | 2023-03-07 | 华中农业大学 | 一株耐热沙门氏菌烈性噬菌体毒株及其应用 |
CN115896041B (zh) * | 2022-10-24 | 2024-05-03 | 华中农业大学 | 一株兼性裂解沙门氏菌和大肠杆菌的广谱噬菌体和应用 |
CN115948348B (zh) * | 2022-11-09 | 2024-01-30 | 聊城大学 | 一种宽谱禽源沙门菌噬菌体及其应用和组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112029732A (zh) * | 2020-09-05 | 2020-12-04 | 菲吉乐科(南京)生物科技有限公司 | 一种耐高温宽裂解谱的沙门氏菌噬菌体及其组合物 |
CN112831474A (zh) * | 2021-01-15 | 2021-05-25 | 瑞科盟(青岛)生物工程有限公司 | 一株宽裂解谱沙门氏菌噬菌体rdp-nsa-19050及其应用 |
-
2021
- 2021-06-30 CN CN202110742848.1A patent/CN113416712B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112029732A (zh) * | 2020-09-05 | 2020-12-04 | 菲吉乐科(南京)生物科技有限公司 | 一种耐高温宽裂解谱的沙门氏菌噬菌体及其组合物 |
CN112831474A (zh) * | 2021-01-15 | 2021-05-25 | 瑞科盟(青岛)生物工程有限公司 | 一株宽裂解谱沙门氏菌噬菌体rdp-nsa-19050及其应用 |
Non-Patent Citations (2)
Title |
---|
Isolation and characterization of a broad-spectrum phage of multiple drug resistant Salmonella and its therapeutic utility in mice;Fang Tanga等;《Microbial Pathogenesis》;20181105;第126卷;193-198页 * |
Isolation, characterization, and application of a novel specific Salmonella;Chenxi Huang等;《Food Research International》;20180601;第111卷;631-641页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113416712A (zh) | 2021-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113416712B (zh) | 一株宽裂解谱沙门氏菌噬菌体及其应用 | |
CN112029732B (zh) | 一种耐高温宽裂解谱的沙门氏菌噬菌体及其组合物 | |
WO2019154032A1 (zh) | 一种宽谱沙门氏菌噬菌体及其应用 | |
CN110438091B (zh) | 一株新的肺炎克雷伯氏菌噬菌体及其应用 | |
CN112680423B (zh) | 一株能同时裂解四种细菌的宽谱大肠杆菌噬菌体及其组合物、试剂盒和应用 | |
CN110846283B (zh) | 宽裂解谱的大肠杆菌噬菌体及其组合物、试剂盒和应用 | |
CN113337480B (zh) | 一株广谱的大肠杆菌噬菌体及其应用 | |
CN113755450B (zh) | 一株大肠杆菌噬菌体gn4-1及其应用 | |
CN113583971B (zh) | 一株可同时裂解大肠杆菌的沙门氏菌噬菌体及其应用 | |
JP5720045B2 (ja) | スタフィロコッカス・アウレウス溶菌性バクテリオファージ | |
CN114717199B (zh) | 一株不具转导耐药基因能力的沙门菌噬菌体ckt1及其应用 | |
CN111647567B (zh) | 一种耐酸的沙门氏菌噬菌体及其组合物、试剂盒和应用 | |
CN110093321B (zh) | 噬菌体AH10-Phage-QY01在制备治疗或防控水产养殖细菌疾病药物的用途 | |
CN113293143B (zh) | 一株可降低鸡白痢沙门氏菌垂直传播的沙门氏菌噬菌体及其应用 | |
CN117050954A (zh) | 一种宽谱沙门氏菌噬菌体vB-SenS-S1及包含该噬菌体的组合物 | |
CN113444695B (zh) | 一株发酵效率高且临床效果好的大肠杆菌噬菌体及其应用 | |
CN114921419B (zh) | 一种鸭疫里氏杆菌噬菌体 | |
CN113430176B (zh) | 一株稳定高效的烈性沙门氏菌噬菌体rdp-sa-21004及其应用 | |
CN113046328B (zh) | 一株化脓隐秘杆菌噬菌体及其医用用途 | |
CN113755451B (zh) | 一株大肠杆菌噬菌体gn6及其应用 | |
CN113881641B (zh) | 一株大肠杆菌噬菌体ep01及其应用 | |
CN117887671A (zh) | 一株防止抗性产生的多价大肠杆菌噬菌体在家禽养殖中的应用 | |
CN117737001A (zh) | 一种防治犬细菌性腹泻的大肠杆菌噬菌体及其应用 | |
CN116286674A (zh) | 一株鸭疫里默氏菌噬菌体vB_RanS_PT24、其噬菌体组合物及其应用 | |
CN117757757A (zh) | 一株沙门氏菌噬菌体及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240125 Address after: 1 / F and 2 / F, building 4, banglun Pharmaceutical Industrial Park, 390 Gaoxin 2nd Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee after: Wuhan grenon Biotechnology Co.,Ltd. Country or region after: China Address before: 430070 No.1 Shizishan, Hongshan District, Wuhan City, Hubei Province Patentee before: HUAZHONG AGRICULTURAL University Country or region before: China |
|
TR01 | Transfer of patent right |